Shared on06 Sep 25
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.
Shared on24 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 0.66%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 0.55%
AnalystConsensusTarget has decreased profit margin from 9.8% to 7.3% and increased future PE multiple from 15.9x to 21.3x.
Shared on26 Mar 25Fair value Decreased 1.20%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 8.12%
AnalystConsensusTarget has decreased profit margin from 11.8% to 9.9% and increased future PE multiple from 13.9x to 16.1x.